Related Experiment Videos
Expanded polytetrafluoroethylene monocuspid valve for right ventricular outflow tract reconstruction
1Department of Cardiac Surgery, Kinki University School of Medicine, Osaka, Japan. singe@med.kindai.ac.jp
The Annals of Thoracic Surgery
|November 28, 2000
Summary
Expanded polytetrafluoroethylene (ePTFE) monocuspid valves show promise for right ventricular outflow tract (RVOT) reconstruction in complex congenital heart defects, with good initial results and acceptable long-term outcomes.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Biomaterials Science
Background:
- Reconstruction of the right ventricular outflow tract (RVOT) is crucial for complex congenital heart defects.
- Various materials have been explored for RVOT reconstruction.
Purpose of the Study:
- To evaluate the efficacy and safety of using expanded polytetrafluoroethylene (ePTFE) monocuspid valves for RVOT reconstruction.
Main Methods:
- A retrospective study of 19 patients (mean age 8.5 years) undergoing RVOT reconstruction.
- Utilized a transannular patch and an ePTFE monocuspid valve between 1982 and 1999.
Main Results:
- No perioperative deaths; significant reduction in RVOT gradient post-surgery (p = 0.0001).
- Good cusp motion and minimal pulmonary regurgitation observed in most patients.
- Long-term follow-up showed mild or better pulmonary regurgitation in 5/8 patients; two reoperations for distal stenosis.
Conclusions:
- ePTFE monocuspid valves appear to be a viable option for RVOT reconstruction.
- The material demonstrates acceptable functional outcomes and durability in this patient cohort.